These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 36077136)

  • 1. From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease.
    Poznyak AV; Litvinova L; Poggio P; Moschetta D; Sukhorukov VN; Orekhov AN
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications.
    Molavi B; Rassouli N; Bagwe S; Rasouli N
    Vasc Health Risk Manag; 2007; 3(6):967-73. PubMed ID: 18200815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the pleiotropic activity of metformin. A glimpse of haemostasis.
    Markowicz-Piasecka M; Sadkowska A; Huttunen KM; Podsiedlik M; Mikiciuk-Olasik E; Sikora J
    Eur J Pharmacol; 2020 Apr; 872():172984. PubMed ID: 32017937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK-dependent mechanisms.
    Bu Y; Peng M; Tang X; Xu X; Wu Y; Chen AF; Yang X
    J Cell Mol Med; 2022 Oct; 26(19):4886-4903. PubMed ID: 36052760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission.
    Wang Q; Zhang M; Torres G; Wu S; Ouyang C; Xie Z; Zou MH
    Diabetes; 2017 Jan; 66(1):193-205. PubMed ID: 27737949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial function and dysfunction: Impact of metformin.
    Nafisa A; Gray SG; Cao Y; Wang T; Xu S; Wattoo FH; Barras M; Cohen N; Kamato D; Little PJ
    Pharmacol Ther; 2018 Dec; 192():150-162. PubMed ID: 30056057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin, Macrophage Dysfunction and Atherosclerosis.
    Feng X; Chen W; Ni X; Little PJ; Xu S; Tang L; Weng J
    Front Immunol; 2021; 12():682853. PubMed ID: 34163481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management.
    Luo F; Das A; Chen J; Wu P; Li X; Fang Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):54. PubMed ID: 31029144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status.
    Cameron AR; Morrison VL; Levin D; Mohan M; Forteath C; Beall C; McNeilly AD; Balfour DJ; Savinko T; Wong AK; Viollet B; Sakamoto K; Fagerholm SC; Foretz M; Lang CC; Rena G
    Circ Res; 2016 Aug; 119(5):652-65. PubMed ID: 27418629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.
    Thakur S; Daley B; Klubo-Gwiezdzinska J
    J Mol Endocrinol; 2019 Aug; 63(2):R17-R35. PubMed ID: 31307011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin: an update.
    Kirpichnikov D; McFarlane SI; Sowers JR
    Ann Intern Med; 2002 Jul; 137(1):25-33. PubMed ID: 12093242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function.
    Ding Y; Zhou Y; Ling P; Feng X; Luo S; Zheng X; Little PJ; Xu S; Weng J
    Theranostics; 2021; 11(19):9376-9396. PubMed ID: 34646376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data.
    Nesti L; Natali A
    Nutr Metab Cardiovasc Dis; 2017 Aug; 27(8):657-669. PubMed ID: 28709719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of metformin with special reference to cardiovascular protection.
    Zilov AV; Abdelaziz SI; AlShammary A; Al Zahrani A; Amir A; Assaad Khalil SH; Brand K; Elkafrawy N; Hassoun AAK; Jahed A; Jarrah N; Mrabeti S; Paruk I
    Diabetes Metab Res Rev; 2019 Oct; 35(7):e3173. PubMed ID: 31021474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.
    Gebrie D; Getnet D; Manyazewal T
    Sci Rep; 2021 Jan; 11(1):137. PubMed ID: 33420333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and the Gut Microbiome in Diabetes.
    Devaraj S; Venkatachalam A; Chen X
    Clin Chem; 2016 Dec; 62(12):1554-1555. PubMed ID: 27650682
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of Oxidative Stress in the Genesis of Atherosclerosis and Diabetes Mellitus: A Personal Look Back on 50 Years of Research.
    Lankin VZ; Tikhaze AK
    Curr Aging Sci; 2017; 10(1):18-25. PubMed ID: 27677837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.
    Palomba S; Falbo A; Zullo F; Orio F
    Endocr Rev; 2009 Feb; 30(1):1-50. PubMed ID: 19056992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin treatment prevents SREBP2-mediated cholesterol uptake and improves lipid homeostasis during oxidative stress-induced atherosclerosis.
    Gopoju R; Panangipalli S; Kotamraju S
    Free Radic Biol Med; 2018 Apr; 118():85-97. PubMed ID: 29499335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.